- Home
- Publications
- Publication Search
- Publication Details
Title
Revisiting Androgen Receptor Signaling in Breast Cancer
Authors
Keywords
-
Journal
ONCOLOGIST
Volume 28, Issue 5, Pages 383-391
Publisher
Oxford University Press (OUP)
Online
2023-03-28
DOI
10.1093/oncolo/oyad049
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Androgen receptor activity in T cells limits checkpoint blockade efficacy
- (2022) Xiangnan Guan et al. NATURE
- Androgen conspires with the CD8 + T cell exhaustion program and contributes to sex bias in cancer
- (2022) Hyunwoo Kwon et al. Science Immunology
- The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer
- (2021) Theresa E. Hickey et al. NATURE MEDICINE
- Efficacy of enobosarm, a selective androgen receptor (AR) targeting agent, correlates with the degree of AR positivity in advanced AR+/estrogen receptor (ER)+ breast cancer in an international phase 2 clinical study.
- (2021) Carlo Palmieri et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive profiling of androgen receptor-positive (AR+) triple-negative breast cancer (TNBC) patients (pts) treated with standard neoadjuvant therapy (NAT) +/- enzalutamide.
- (2020) Bora Lim et al. JOURNAL OF CLINICAL ONCOLOGY
- A Randomized Placebo-Controlled Phase 2 Trial Evaluating Exemestane With or Without Enzalutamide in Patients With Hormone Receptor-positive Breast Cancer
- (2020) Ian Krop et al. CLINICAL CANCER RESEARCH
- A high AR:ERα or PDEF:ERα ratio predicts a sub-optimal response to tamoxifen therapy in ERα-positive breast cancer
- (2019) Lu Cao et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells
- (2019) Francesca De Amicis et al. BMC CANCER
- TBCRC 032 IB/II Multicenter Study: Molecular insights to AR antagonist and PI3K inhibitor efficacy in patients with AR+ metastatic triple-negative breast cancer
- (2019) Brian D. Lehmann et al. CLINICAL CANCER RESEARCH
- The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease Outcome
- (2018) Carmela Ricciardelli et al. CLINICAL CANCER RESEARCH
- The role of the AR/ER ratio in ER-positive breast cancer patients
- (2018) Nelson Rangel et al. ENDOCRINE-RELATED CANCER
- Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer
- (2018) Tiffany A. Traina et al. JOURNAL OF CLINICAL ONCOLOGY
- Non-canonical AR activity facilitates endocrine resistance in breast cancer
- (2018) KeeMing Chia et al. ENDOCRINE-RELATED CANCER
- The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression Data
- (2016) Ivana Bozovic-Spasojevic et al. CLINICAL CANCER RESEARCH
- Complete Response of Metastatic Androgen Receptor–Positive Breast Cancer to Bicalutamide: Case Report and Review of the Literature
- (2016) Claudia Arce-Salinas et al. JOURNAL OF CLINICAL ONCOLOGY
- Cooperative Dynamics of AR and ER Activity in Breast Cancer
- (2016) N. C. D'Amato et al. MOLECULAR CANCER RESEARCH
- Expression of Androgen Receptor in Estrogen Receptor–positive Breast Cancer
- (2016) Anil Agrawal et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer
- (2015) Andrew Ciupek et al. BREAST CANCER RESEARCH AND TREATMENT
- Influence of Androgen Receptor Expression on the Survival Outcomes in Breast Cancer: A Meta-Analysis
- (2015) Yoonseok Kim et al. Journal of Breast Cancer
- Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide In Vivo
- (2015) V. N. Barton et al. MOLECULAR CANCER THERAPEUTICS
- A Functionally Significant Cross-talk between Androgen Receptor and ErbB2 Pathways in Estrogen Receptor Negative Breast Cancer
- (2015) Ali Naderi et al. NEOPLASIA
- AR collaborates with ERα in aromatase inhibitor-resistant breast cancer
- (2014) Yassine Rechoum et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
- (2013) A. Gucalp et al. CLINICAL CANCER RESEARCH
- Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis
- (2013) F. E. Vera-Badillo et al. JNCI-Journal of the National Cancer Institute
- Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancer
- (2013) Eriko Tokunaga et al. Cancer Medicine
- Decreased Androgen Receptor Expression Is Associated With Distant Metastases in Patients With Androgen Receptor–Expressing Triple-Negative Breast Carcinoma
- (2012) Lisa M. Sutton et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Minireview: The Androgen Receptor in Breast Tissues: Growth Inhibitor, Tumor Suppressor, Oncogene?
- (2012) T. E. Hickey et al. MOLECULAR ENDOCRINOLOGY
- FoxA1 is a Key Mediator of Hormonal Response in Breast and Prostate Cancer
- (2012) Jessica L. L. Robinson et al. Frontiers in Endocrinology
- Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
- (2011) Min Ni et al. CANCER CELL
- Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women
- (2011) R. Hu et al. CLINICAL CANCER RESEARCH
- Androgen receptor expression is usually maintained in initial surgically resected breast cancer metastases but is often lost in end-stage metastases found at autopsy
- (2011) Ashley Cimino-Mathews et al. HUMAN PATHOLOGY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer
- (2011) Dabei Tang et al. MEDICAL ONCOLOGY
- Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray
- (2011) Jiehua He et al. MEDICAL ONCOLOGY
- Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study
- (2011) Laura C Collins et al. MODERN PATHOLOGY
- Molecular biology of androgen insensitivity
- (2011) Jarmo Jääskeläinen MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers
- (2010) Isabella Castellano et al. BREAST CANCER RESEARCH AND TREATMENT
- FOXA1 is a key determinant of estrogen receptor function and endocrine response
- (2010) Antoni Hurtado et al. NATURE GENETICS
- Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers
- (2010) Donata Micello et al. VIRCHOWS ARCHIV
- Expression of androgen receptors in primary breast cancer
- (2009) S. Park et al. ANNALS OF ONCOLOGY
- Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells
- (2009) Francesca De Amicis et al. BREAST CANCER RESEARCH AND TREATMENT
- Androgen Receptor Inhibits Estrogen Receptor- Activity and Is Prognostic in Breast Cancer
- (2009) A. A. Peters et al. CANCER RESEARCH
- Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation
- (2009) Leo A Niemeier et al. MODERN PATHOLOGY
- Estrogen regulated gene expression in response to neoadjuvant endocrine therapy of breast cancers: tamoxifen agonist effects dominate in the presence of an aromatase inhibitor
- (2008) Djuana M. E. Harvell et al. BREAST CANCER RESEARCH AND TREATMENT
- Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers
- (2008) Yoshinari Ogawa et al. International Journal of Clinical Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now